🧬Mismatch repair in pancreatic cancer JAMA Oncology ✅Although it is rare, MSI should be tested in pancreatic cancer ✅Median IO duration: 27.7 months, DCR: 80% 👉doi:10.1001/jamaoncol.2024.3651 Catherine O’Connor Emily Harrold Wungki Park, MD MS Eileen M O’Reilly #cancer #Oncology #MedX

The study results suggest that orthogonal MS testing is critical to identify MSI-H in PC and patients with MSI-H PC should be treated with immune checkpoint blockade therapy. ja.ma/4gbePuZ Catherine O’Connor Eileen M O’Reilly

Great investigation of MMR deficiency and Lynch Syndrome in pancreatic cancer. The low incidence of MMR deficiency in PDAC has made analysis of these cases challenging in the past, but it's now quite clear that MMR testing is therapeutically important for PDAC patients.

Very honored to have been nominated for the Cholangiocarcinoma Oncology Nurse of Excellence (ONE) Award! 🩺💚 Voting ends TONIGHT—please take a moment to watch my video testimonial & cast your vote. 🗳️ Thank you! 🙏 ⁦Ghassan Abou-Alfa⁩ ⁦Cholangiocarcinoma Foundation⁩ ccanewsonline.com/summit/one-awa…

Extremely fortunate 💜to have the best mentor Eileen M O’Reilly and mentee Catherine O’Connor A strong teamwork at Memorial Sloan Kettering Cancer Center We are sharing each other's slides in transatlantic presentations at #AACRpan24 and #ESMO24 A lot of active research👨‍🔬MSKCC Center for Pancreatic Cancer Research Congrats! Keynote 📢speech

An incredible team from MSK are sharing research their #ESMO24.

Best ⚡️talk for last!! Incredible presentation + poster on how hepcidin-mediated iron sequestration limits CD8+ tumor infiltrating lymphocytes in PDAC Joshua Schoenfeld 🧬😊

1 more week to see Lifeline Musical!!

The best last-minute dinner plans!! Grateful to have such wonderful mentors and missing the team in NYC a bit extra today 🥹💜Wungki Park, MD MS Eileen M O’Reilly Mary Helen Larsen

An important single institution study led by Eileen M O’Reilly from Memorial Sloan Kettering Cancer Center in JNCI Adjuvant Modified FOLFIRINOX for Resected Pancreatic Adenocarcinoma (PDAC): Clinical Insights and Genomic Features from a Large Contemporary Cohort academic.oup.com/jnci/advance-a… With all

Delighted to have been a part of this study and to see it in print 🙌.

Adjuvant mFOLFIRINOX for Resected Pancreatic Adenocarcinoma (PDAC): Clinical Insights and Genomic Features from a Large Contemporary Cohort academic.oup.com/jnci/article-a… Congrats to Fergus Keane Catherine O’Connor Fiyinfolu (Folu) Balogun Drew Moss for very thoughtful compilation synthesis of data!

Excited to have this out!! Was so fun to work with Drew Moss, Fergus Keane, Fionnuala Crowley + more (as always 😊)

Excited to present our study on the association between inflammatory diet pattern and survival in colon cancer - catch it Sunday 6/1 at 4:30 Hall B1!

Huge congrats to Dr. Jonathan Lee Jonathan W Lee and the Memorial Sloan Kettering Cancer Center team for presenting a first-of-its-kind clinico-genomic characterization of PALB2-mutated pancreatic cancer at #ASCO25! 🧬🩺 📊 Key takeaways: — gPALB2 patients presented younger, with more family history

Immediately practice changing and deserves discussion with each pt! The first RCT supporting structured exercise after adjuvant therapy for colon cancer. It’s striking how exercise improves survival, especially compared to drugs with FDA approval and payer support. 👀 #ASCO25

Early-onset gastrointestinal cancers: comprehensive review and future directions ➡️doi.org/10.1093/bjs/zn… ⏰Early-onset GI cancers represent clinically distinct disease entities that are associated with unique challenges in screening, management, and survivorship 🚨A better

Check out our review on early-onset GI cancers now out in BJS! Rates of GI cancers in people under 50 are rising 📈 We discuss what is known, the unique needs of this growing patient population, and where to go from here. Catherine O’Connor Kimmie Ng, MD, MPH Dana-Farber's Young-Onset Colorectal Cancer Center

A new report from Dana-Farber highlights rising rates of GI cancers in young adults - not just #colorectal, but also #pancreatic, #esophageal, #gastric, #biliary & more. Dana-Farber's Young-Onset Colorectal Cancer Center Kimmie Ng, MD, MPH Sara Khosrowjerdi Char, MD Catherine O’Connor Read more: bit.ly/40D0kd8